Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127309311 | 12730931 | 1 | I | 20160729 | 0 | 20160909 | 20160909 | DIR | FDA-CTU | 58.00 | YR | F | N | 250.00000 | LBS | 20160826 | N | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127309311 | 12730931 | 1 | PS | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Intramuscular | N | D | 610268M | 20190101 | 0 | 1 | DF | SUSPENSION FOR INJECTION | 1X | |||
| 127309311 | 12730931 | 2 | C | LEVOTHROXINE SODIUM | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 3 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 4 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 5 | C | ZONEGRAN | ZONISAMIDE | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 6 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 7 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 8 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 9 | C | CELECOXIB. | CELECOXIB | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 10 | C | DICLOFENAC | DICLOFENAC | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 11 | C | TIZANIDINE. | TIZANIDINE | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 12 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 13 | C | COLACE | DOCUSATE SODIUM | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 14 | C | PROBIOTIC | PROBIOTICS NOS | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 15 | C | MULTI VITAMIN | VITAMINS | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 16 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 127309311 | 12730931 | 17 | C | GLUCOSAMINE/CHONDROITIN | 2 | 0 | |||||||||||||
| 127309311 | 12730931 | 18 | C | ASPRIN | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127309311 | 12730931 | 1 | Cystitis |
| 127309311 | 12730931 | 1 | Urinary tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127309311 | 12730931 | DS |
| 127309311 | 12730931 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127309311 | 12730931 | Drug hypersensitivity | |
| 127309311 | 12730931 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127309311 | 12730931 | 1 | 20160729 | 20160729 | 0 |